Antidepressant effects of nicotine in an animal model of depression

Psychopharmacology

Volumn 142, Issue 2, 1999, Pages 193-199

  Tizabi, Yousef ^a   Overstreet, David H ^b   Rezvani, Amir H ^b   Louis, Vely A ^a   Clark Jr , Elijah ^b   Janowsky, David S ^b   Kling, Mitchel A ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model of depression; FSL and FRL rats; Nicotine; Nicotinic receptor

Indexed keywords

ALPHA BUNGAROTOXIN; CYTISINE; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CHOLINERGIC STIMULATION; CIGARETTE SMOKING; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG EFFECT; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HYPOTHESIS; INFERIOR COLLICULUS; LOCOMOTION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SWIMMING; TASK PERFORMANCE;

ALKALOIDS; ANIMALS; ANTIDEPRESSIVE AGENTS; AZOCINES; BINDING SITES; BODY TEMPERATURE; BUNGAROTOXINS; DEPRESSION; DISEASE MODELS, ANIMAL; IODINE RADIOISOTOPES; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; QUINOLIZINES; RATS; RECEPTORS, NICOTINIC; TRITIUM;

EID: 0032955920     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050879     Document Type: Article

References (36)

1. Arneric SP, Holladay MW, Sullivan JP (1996) Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease. Exp Opin Invest Drugs 5:79-100
2. Barrantes GE, Rogers AT, Lindstrom J, Wonnacott S (1995) α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α-7 subunits and up-regulation by nicotine treatment. Brain Res 672: 228-236
3. 3H] nicotine binding sites in human brain. J Neurochem 50:1243-1247
4. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P (1998) Major depression and stages of smoking - a longitudinal investigation. Arch Gen Psychiatry 55:161-166
6. Clarke PBS (1990) Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem Pharmacol 40:1427-1432
7. Covey LS, Glassman AH, Stetner F (1997) Major depression following smoking cessation. Am J Psychiatry 154:263-265
8. Crooks PA, Dwoskin LP (1997) Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem Pharmacol 54:743-753
9. Dilsaver SC, Coffman JA (1989) Cholinergic hypothesis of depression: a reappraisal. J Clin Psychopharmacol 9:173-179
10. Flores C M, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37
11. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerly W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592
12. Gilbert DG (1996) Depression, smoking, and nicotine: toward a bioinformational situation by trait model. Drug Dev Res 38: 267-277
13. Glassman AH (1993) Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 150:546-553
14. Janowsky DS, Risch SC (1987) Role of acetylcholine mechanisms in the affective disorders. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 527-534
15. Janowsky DS, Overstreet DH, Nurnberger JI Jr (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54:335-344
16. Kendler KS, Neal MC, MacLean CL, Heath AC, Eaves LJ, Kessler RC (1993) Smoking and major depressions: a causal analysis. Arch Gen Psychiatry 50:36-43
17. Levin ED, Rosecrans JA (1994) Promise of nicotinic-based therapeutic treatments. Drug Dev Res 31:1-2
18. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532
19. Marks MJ, Grady SR, Collins AC (1993) Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268-1276
20. Museo E, Wise RA (1995) Cytisine-induced behavioral activation: delineation of neuroanatomical locus of action. Brain Res 670:257-263
21. Ochoa ELM, Li L, McNamee MG (1992) Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol Neurobiol 4:251-287
22. Overstreet DH (1993) The Flinders Sensitive Line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17:51-68
23. Overstreet DH (1995) Differential effects of nicotine in inbred and selectively bred rodents. Behav Genet 25:179-85
24. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 121:27-37
25. Overstreet DH, Miller CS, Janowsky DS, Russell RW (1996) Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 111:119-134
26. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39: 9-12
27. Pucilowski O, Overstreet DH (1993) Effect of chronic antidepressant treatment on response to apomorphine in selectively bred rat strains. Brain Res Bull 32:471-475
28. Salin-Pascual RJ, Drucker-Colin R (1998) A novel effect of nicotine on mood and sleep in major depression. NeuroReport 9: 57-60
29. Salin-Pascual RJ, de la Fuente JR, Galicia-Polo I, Drucker-Colin R (1995) Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121:476-479
30. Sanderson EM, Drasdo AL, McCrea K, Wonnacott S (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 617:349-352
31. Schiller GD, Pucilowski O, Wienicke C, Overstreet DH (1992) Immobility-reducing effects of antidepressants in a genetic animal model of depression. Brain Res Bull 28:821-823
32. Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 228:214-216
33. Semba J, Mataki C, Yamada S, Nankai M, Toru M (1998) Antidepressantlike effects of chronic nicotine on learned helplessness paradigms in rats. Biol Psychiatry 43:389-391
34. Shoaib M, Stolerman IP (1994) Locomotor activity after nicotine infusions into the fourth ventricle of rats. Pharmacol Biochem Behav 48:749-754
35. Tizabi Y, Mastropaolo J, Park CH, Riggs RL, Powell D, Rosse RB, Deutsch SI (1998) Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: psychiatric implications. Psychopharmacology 140:202-205
36. Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216-219